Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Bougas

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|March 26, 2015
The slow dissociation rate of K-1602 contributes to the enhanced inhibitory activity of this novel alkyl-aryl-bearing fluoroketolideMarios Krokidis, Anthony Bougas, Maria Stavropoulou, et al.
Amino Acids|March 12, 2017
Dual effect of chloramphenicol peptides on ribosome inhibitionAnthony Bougas, Ioannis A Vlachogiannis, Dimitrios Gatos, et al.
ACS Synthetic Biology|January 4, 2025
ATP Regeneration from Pyruvate in the PURE SystemSurendra Yadav, Alexander J P Perkins, Sahan B W Liyanagedera, et al.
Journal of Visualized Experiments : Jove|September 8, 2025
Refinement of OnePot PURE and Crude Ribosome Production for Reproducible Cell-free Protein SynthesisSahan B W Liyanagedera, Anthony Bougas, Surendra Yadav, et al.
Antibiotics (Basel, Switzerland)|April 30, 2021
New Chloramphenicol Derivatives with a Modified Dichloroacetyl Tail as Potential Antimicrobial AgentsArtemis Tsirogianni, Georgia G Kournoutou, Anthony Bougas, et al.
RNA (New York, N.Y.)|February 9, 2019
High-resolution crystal structures of ribosome-bound chloramphenicol and erythromycin provide the ultimate basis for their competitionMaxim S Svetlov, Elena Plessa, Chih-Wei Chen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Enzyme Inhibition and Medicinal Chemistry|March 26, 2015
The slow dissociation rate of K-1602 contributes to the enhanced inhibitory activity of this novel alkyl-aryl-bearing fluoroketolideMarios Krokidis, Anthony Bougas, Maria Stavropoulou, et al.
Amino Acids|March 12, 2017
Dual effect of chloramphenicol peptides on ribosome inhibitionAnthony Bougas, Ioannis A Vlachogiannis, Dimitrios Gatos, et al.
ACS Synthetic Biology|January 4, 2025
ATP Regeneration from Pyruvate in the PURE SystemSurendra Yadav, Alexander J P Perkins, Sahan B W Liyanagedera, et al.
Journal of Visualized Experiments : Jove|September 8, 2025
Refinement of OnePot PURE and Crude Ribosome Production for Reproducible Cell-free Protein SynthesisSahan B W Liyanagedera, Anthony Bougas, Surendra Yadav, et al.
Antibiotics (Basel, Switzerland)|April 30, 2021
New Chloramphenicol Derivatives with a Modified Dichloroacetyl Tail as Potential Antimicrobial AgentsArtemis Tsirogianni, Georgia G Kournoutou, Anthony Bougas, et al.
RNA (New York, N.Y.)|February 9, 2019
High-resolution crystal structures of ribosome-bound chloramphenicol and erythromycin provide the ultimate basis for their competitionMaxim S Svetlov, Elena Plessa, Chih-Wei Chen, et al.
Pageof 1